Financhill
Back

Soleno Therapeutics Quote, Financials, Valuation and Earnings

U.S. Government Report Alert Tuesday

Discover the Secret Loophole
Buy
65

SLNO
Soleno Therapeutics

Last Price:
57.36
Seasonality Move:
33.56%

7 Day Trial

ALL ACCESS PASS

$ 7

"This Changes Everything" - Trump Hands Millions Massive IRS Gift

Learn More Here

Soleno Therapeutics Price Quote

$57.36
-1.86 (-3.14%)
(Updated: November 12, 2024 at 5:55 PM ET)

Soleno Therapeutics Key Stats

Buy
65
Soleno Therapeutics (SLNO) is a Buy

Day range:
$57.73 - $59.75
52-week range:
$21.39 - $59.75
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
2,807.50
P/B ratio:
9.65%

Volume:
535.6K
Avg. volume:
706.5K
1-year change:
169.18%
Market cap:
$2.6B
Revenue:
$0
EPS:
$-3.35

How Much Does Soleno Therapeutics Make?

Data Unavailable

Is Soleno Therapeutics Growing As A Company?

Data Unavailable

Soleno Therapeutics Stock Price Performance

What Is Soleno Therapeutics 52-Week High & Low?

Soleno Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Soleno Therapeutics?

Is Soleno Therapeutics Cash Flow Positive?

  • What Is SLNO Cash Flow From Operations?
    Cash flow from operations (TTM) is -$51.4M
  • What Is Soleno Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $279.5M
  • What Is Soleno Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$232.1M

Soleno Therapeutics Return On Invested Capital

Data Unavailable

Soleno Therapeutics Earnings Date & Stock Price

Soleno Therapeutics Competitors

  • Who Are Soleno Therapeutics's Competitors?
    Below is a list of companies who compete with Soleno Therapeutics or are related in some way:
    • ACADIA Pharmaceuticals Inc (ACAD)
    • Alnylam Pharmaceuticals Inc (ALNY)
    • Bioventus Inc (BVS)
    • Fulcrum Therapeutics Inc (FULC)
    • KalVista Pharmaceuticals Inc (KALV)

Soleno Therapeutics Dividend Yield

Soleno Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 5
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 74.25
Upside from Last Price: 25.38%

Major Shareholders

  • How many SLNO shares are owned by institutional investors?
    66.9M SLNO shares are owned by institutional investors
  • How many SLNO shares are owned by insiders?
    1.8M SLNO shares are owned by insiders